IHS Chemical Week

World News and Views :: Top of the News

Lonza and Australian Firm Establish Manufacturing Alliance

11:34 AM MDT | October 6, 2011 | Deepti Ramesh

Lonza says it has entered into a strategic alliance with Mesoblast (Melbourne, Australia), a developer of innovative biological products for regenerative medicine, for clinical and long-term commercial production of Mesoblast’s off-the-shelf allogeneic adult stem cell products. The alliance will provide Mesoblast with certainty of capacity to meet long-term global supply of its proprietary mesenchymal precursor cell (MPC) products. “The cell therapy market is anticipated to become a major growth industry with the potential to mirror the growth we have...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa